|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/18 | |
| A61P 3/00 |
| (11) | Patento numeris | 2694092 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12761825.4 |
| Europos patento paraiškos padavimo data | 2012-04-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-02-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-01-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/032415 |
| Data | 2012-04-05 |
| (87) | Numeris | WO 2012/138919 |
| Data | 2012-10-11 |
| (30) | Numeris | Data | Šalis |
| 201161473583 P | 2011-04-08 | US |
| (72) |
XIONG, YuMei, US
LI, Yang, US
YEH, Wen-Chen, US
SHAN, Bei, US
SHENG, Jackie Zeqi, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) |
| METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) |